Recitals
WHEREAS, the Company is a special purpose acquisition company, also known as a blank check company, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses;
WHEREAS, the Company has entered into a Share Purchase Agreement with EUDA Health Limited, a British Virgin Islands business company (“EUDA Health”), Watermark Developments Limited, a British Virgin Islands business company (the “Seller”) and Kwong Yeow Liew, acting as Representative of the Indemnified Parties (the “Indemnified Party Representative”), pursuant to which a business combination between the Company and EUDA Health will be effected through the purchase by the Company of all of the issued and outstanding shares of EUDA Health from the Seller (the “Share Purchase”), which Share Purchase Agreement has been amended by the Amendment No. 1 to the Share Purchase Agreement dated as of May 30, 2022, Amendment No. 2 to the Share Purchase Agreement dated as of June 10, 2022 and Amendment No. 3 to the Share Purchase Agreement dated as of September 7, 2022 (as so amended the “SPA”), and the Company has filed a definitive proxy statement with the U.S. Securities and Exchange Commission (the “Commission”) that will seek, among other things, shareholder approval of the Share Purchase at a special meeting of shareholders (the “Share Purchase Meeting”); and
WHEREAS, the Parties wish to enter into this Agreement, pursuant to which the Company shall purchase from Investor, and Investor may sell and transfer to the Company, in each case, subject to the conditions set forth herein, up to 125,000 ordinary shares, no par value (“Ordinary Shares”), of the Company held by Investor (the “Shares,” which term shall include Additional Shares, as defined herein) on the terms set forth herein.
NOW, THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the Parties agree as follows:
【参考訳】前提条件
当社は、合併、資本交換、資産買収、株式購入、組織再編、または 1 つ以上の企業との同様の事業統合を目的として設立された特別目的買収会社であり、白紙委任会社としても知られている；
当社は、英領ヴァージン諸島の事業会社である EUDA Health Limited（以下「EUDA Health」）、英領ヴァージン諸島の事業会社である Watermark Developments Limited（以下「売主」）、および被補償当事者の代表を務める Kwong Yeow Liew（以下「被補償当事者代表」）との間で株式売買契約を締結した、 この株式売買契約は、当社が売主から EUDA ヘルス社の発行済株式の全部を取得することにより、当社と EUDA ヘルス社との間の企業結合（以下「本株式売買」といいます。この株式売買契約は、2022年5月30日付の株式売買契約の修正第1号、2022年6月10日付の株式売買契約の修正第2号、および2022年9月7日付の株式売買契約の修正第3号（以下、修正後の「本株式売買契約」）によって修正され、当社は、臨時株主総会（以下、「本株式売買総会」）における本株式売買の株主承認などを求める最終委任状を米国証券取引委員会（以下、「委員会」）に提出しました。
両当事者は本契約の締結を希望しており、本契約に基づき、当社は投資家から株式を購入し、投資家は当社に対し、本契約に定める条件に従い、投資家が保有する当社の額面無額面の普通株式（以下「普通株式」）を125,000株を上限として売却および譲渡することができる。
よって、両当事者は、本契約に含まれる前提条件、表明、保証、および相互の誓約、ならびにその他の正当かつ貴重な対価（これらの受領、十分性および妥当性は本契約により承認される）の対価として、以下のとおり合意する：
